Pancreatic Cancer Research

ResearcherXiamen UniversityNo recent work listed

Jiaqi Shen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7435-4106; OpenAlex author ID A5102987613. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2020: 3 papers

Papers 3

  1. LncRNA CASC19 contributed to the progression of pancreatic cancer through modulating miR-148b/E2F7 axis. Last author DOI 10.26355/eurrev_202010_23399↗
  2. Magnolol Suppresses Pancreatic Cancer Development In Vivo and In Vitro via Negatively Regulating TGF-β/Smad Signaling. First author DOI 10.3389/fonc.2020.597672↗
  3. MicroRNA-4516 suppresses pancreatic cancer development via negatively regulating orthodenticle homeobox 1. Co-author DOI 10.7150/ijbs.45933↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tao Shan · 2 shared papers, 2020 · strength 0.21
  2. Gang Cao · 2 shared papers, 2020 · strength 0.21
  3. Shuo Chen · 2 shared papers, 2020 · strength 0.21
  4. T Lu · 1 shared paper, 2020 · strength 0.16
  5. Yang Liu · 1 shared paper, 2020 · strength 0.11
  6. Junhui Li · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.